Komori
Other Disclosures3915TerraSky Co.,LtdInformation and Communications, Services and Others

Extending molecular dynamics simulations supporting materials development and drug discovery to a quantum computing platform

Quemix and DENSO CORPORATION jointly developed a hybrid computing platform for executing molecular dynamics calculations on quantum computers and completed a proof of concept for predicting the chemical state of a hydrogen molecule.

Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Quantum–classical hybrid molecular dynamics (MD) frameworkMolecular dynamics (MD) simulation platform technologyProbabilistic imaginary-time evolution method (PITE®)
Applicable field (uses covered by this announcement)
Next-Generation Battery MaterialsPolymer materialsCatalystsDrug DiscoveryMaterials developmentChemical process optimization
What the company reported numerically
Quantitative Effects

The companies demonstrated that highly accurate chemical-state predictions can be made with fewer computational steps than conventional methods. Quantitative impact: Not disclosed.

Relationship between the counterparty and the company
TerraSky Co.,Ltd3915
Relationship with the Company

Quemix and DENSO CORPORATION conducted joint research. Quemix is a consolidated subsidiary of テラスカイ.

CounterpartyName of alliance partner

Head office: Kariya, Aichi Prefecture; President and Representative Director: Hayashi Shinnosuke (林新之助). Other business activities, capital and year established: Not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Q2B 2026 Tokyo official website

Announced details
ItemDetails
Names of Products / Services CoveredQuantum–classical hybrid molecular dynamics (MD) framework, Molecular dynamics (MD) simulation platform technology, Probabilistic imaginary-time evolution method (PITE®)
CounterpartyName of alliance partner
Counterparty overviewHead office: Kariya, Aichi Prefecture; President and Representative Director: Hayashi Shinnosuke (林新之助). Other business activities, capital and year established: Not disclosed.
Relationship with the CompanyQuemix and DENSO CORPORATION conducted joint research. Quemix is a consolidated subsidiary of テラスカイ.
Applicable areaNext-Generation Battery Materials, Polymer materials, Catalysts, Drug Discovery, Materials development, Chemical process optimization
Quantitative EffectsThe companies demonstrated that highly accurate chemical-state predictions can be made with fewer computational steps than conventional methods. Quantitative impact: Not disclosed.
SourceQ2B 2026 Tokyo official website
Items this document does not state (11)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To address challenges in molecular dynamics calculations, including computational load, distribution-function representation, temperature control and the readout of physical property values, and to support the industrial application of quantum computers.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Extending molecular dynamics simulations supporting materials development and drug discovery to a quantum computing platform | TerraSky Co.,Ltd (3915) timely disclosure | Komori